Bouncing off life’s ups and downs, golf has been a roller-coaster for me over the past few months. After a very tough trip to Florida and Houston for the Coleman at Seminole, and then the Carlton Woods event in Houston, I considered taking some time away from the game and this Blog. We all go through life’s ups and downs, and between the significant drop in HSDT combined with some really shitty golf, I wasn’t sure I had much to write about here.

All slumps must come to an end, for both me and HSDT. What I’ve realized is that without the “rock bottom” we’d never fully enjoy the rise out of the hole. I’m not saying I’ve had any recent success, but I achieved a baby-step in finishing T6 in the NCGA Mid Am at Poppy Hills on June 8th and 9th with rounds of 72-70. Not quite in the same league as my best ball partner Jason Anthony, who lit it up with 67-67 for -8 total. Jason and I had some success in the USGA Four Ball at Bandon Dunes a the end of May qualifying T11 and making it to the round of 16. Jason is playing some inspired golf, and as a newly wed as of this past Saturday, he should have a great round today in the first round of the California State amateur at MPCC today.

So why today am I adding to my HSDT position? I’ve either been drinking too much of the HSDT coolaid, or I’ve found the next big thing that will eventually go up, stay up, and even perhaps go up 100X from the levels its trading at now. From everything I’ve heard, the device is working in Canada, and changing lives. They recently announced the addition of three new clinics, which I’m sure is due to the demand and results they are seeing in their first two clinics. Additionally the FDA is now only asking the company to run a 5 week PT (Physical Training) trial for 5 weeks. The FDA is interested in seeing the difference between just straight PT vs the use of the PoNS device combined with PT. My guess is at least 6-9 months will be needed to recruit, run, and present the results to the FDA. If then the PoNS device gets approval, there should be a significant rise in the shares (I think at least back to $10) I will admit there is a VERY negative stigmatism behind this company along with a very large short position. Who wins will be decided solely on the success of the PoNS device going forward. This is not for the faint-of-heart type of investor, but if you believe in their product, and its potential to help millions of people with any kind of brain disorder, then I would urge you to take a shot here, knowing that some patience is required. These share may trade all the way back to $2.00 or even lower, I don’t know. But as results keep coming out of Canada, I believe that we should see some buying coming in.

Since I am constantly in search of the truth, I will soon be sharing three things with you.

  1. A new and improved way to reduce inflammation and end your use of Ibuprofen, and other anti-inflammatory drugs that are harmful to your body.
  2. I will share a device with you that I have found which is being used by professional athletes all over the world that creates better blood flow, and healing
  3. I will share with you a way to save on 90% of all your Hotel bookings as you travel the Globe (it could be 100% but I am being conservative)

And lastly I will tell you more about the benefits I am getting from seeing a top professional hypnotist.

So in summary in my next Post I’ll show you how you can get pain free while increasing your blood flow, extending your life whilst staying in better hotels for less.



The challenge with golf is always being able to keep up with your workout routine while away from home. The link below is 11 minutes long and will give you the most important key exercises that you need to maintain and increase your club speed.


Let me know how this works for you!


 All aspects of application were fine except:

They want the company to distinguish benefit from the device vs physical therapy alone.  This contrasted with previous guidance that the voluminous history of physical therapy alone over the past 50 years and the fact that all patients in the trial had exhausted physical therapy would stand as a control group.  That is why they were granted co primary endpoints of difference between high and low stim groups (just fell short of statistical significance) as well as a change from baseline (highly statistically significant).  The FDA bought off on the trial design and endpoints and even now is acknowledging no safety issues and overall excellent results.  Management will meet with the FDA to arrive at a consensus on how they can do a study to isolate the effect of the device.  One idea is to do a crossover study at the existing sites which continue to enroll patients in a clinical experience program.I’m told that 40 paying patients are being treated in Canada and doing extremely well.

I’ve understandably have received a lot of harsh comments which perhaps I deserve. What you learn when investing in these tiny cap stocks is they can go up 10-100x or they can go to ZERO. I have no idea where this stock goes now. I estimate the company has almost $20,000,000 in the bank and will slash costs. Will the PoNS device end up helping millions of suffering patients from all kinds of neurological diseases? My guess would still be yes.

Back to the point of small cap stocks- 18 months ago when I recommended LFVN at $3.50 a share, I knew it had zero chance of going to zero, and a great chance of going to $10. It went as high as $17. One comment was that I had a winner 10 years ago, but actually I’ve had two winners in the past 3 years. One that went up 400% and LFVN that went up at least 400%. I don’t get paid to give these stock ideas out, these are companies that I know and like. Will HSDT survive this? I am not sure, and with my account at Schwab down $250,000 today, I am still in shock at this news.

I will continue to provide updates to those of you that took my suggestion to buy Helius, a company that is helping people now in Canada, and hopefully one day the rest of the world. If you want to tell me how awful I am, please fire away as I have tough skin.

I hope to get back to writing about golf, and ways to improve your game. I sincerely apologize to those of you that this news and drop in HSDT has hurt. I hope that we all see better days for this company.

Anyone with a GOOD cure for the YIPS, I’d like to hear from you so I can share with the others.

Stay tuned, better days ahead!


I wasn’t sure if I wanted to post this, as many of these exercises are my “secret weapon” in golf. Then I realized I mainly play against the older guys and they are too lazy to try these:)

If you want to improve, stop watching Martin Chuck give you something that doesn’t work, and try these exercises and tell me what helped you most? I give you a money back guarantee that these will. Oh, there is no money required to do these.

Jennifer is the best TPI trainer I’ve ever worked with, and she knows what she’s doing. There is one exercise not on here that I will video that is my #1 exercise (and Jim Furyk’s). So stay tuned for that. But in the meantime try a few of these, the are NOT EASY!!

These specific exercises will significantly improve your range of motion and length of your backswing. And give you a LOT more distance on all your shots.


Let me know how they work for you!!


If you want to keep up with what’s going on in golf, not only the pro game, but with the amateur events then discovered Global Golf Post +

It’s the new subscription service from our favorite golf publication. It delivers original, premium quality content you can’t find anywhere else without any advertising. Of course, you’ll find more of the kind of coverage of the amateur game you have come to expect from GGP. Get a subscription today for just $7/ per month at globalgolfpost.com.

Stay Tuned

Featured Interview: CEO Phillipe Deschamps of Helius Medical Technologies, Inc. (NASDAQ: HSDT)

Ok folks, I PROMISE I will not beat a dead horse here talking about Helius. BUT TAKE 10 Minutes and listen to the interview with the CEO, the link is below!

But after being in the finance field for over 30 years, I have developed a reliable intuitive ability for special situations. This is a special situation where only one company global has a neurological product available that will help millions of people with many different kinds of neurological disorders like MS, Stroke and of course TBI.

The science here is VERY solid, and I’m in this at and average price over $10 a share, and am more bullish than ever. This has upside in the 50-100X range like when I bought ILMN at $3 10 years ago (up 100X+).

So listen to this interview, and remember I told you about this opportunity when the market cap of this company was less than $200M while having a market opportunity in the many billions.

Would love your comments

Interview with Helius Medical CEO


Danielle Suh captures 2019 SF City woman’s title at age 17

In the SF City woman final match 17 year old Danielle Suh defeated Aman Sangha on the 38th hole with two brilliant shots on Hardings tough 2nd hole, leading to a conceded 3 foot putt for birdie and the title.

As history tells us, 17 is no longer considered young in woman golf, as now 13 and 14 year old young ladies are playing world class golf. The men, that’s a different story as a male body will take longer to mature.

I watched this match from the 16th hole thru the 2nd and final hole. Both these young ladies played great golf, and have bright futures in the game.


Here is my interview with Danielle

Randy Haag interview with Women’s SF Champion Danielle Suh


Stay tuned for an interview with the CEO of HSDT you won’t want to miss